Health
Crystal structures of nanobodies could aid the design of COVID-19 therapies – News-Medical.Net
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease…

Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
The team describes the X-ray crystal structures of three synthetic nanobodies (sybodies) that bind to the receptor-binding domain (RBD) of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Superposing the structures onto models of the…
Continue Reading